Diversity in medical research
Medical research and clinical trials lack African, Asian, and Hispanic American participants. This makes it harder to determine if discoveries will be effective among these underrepresented populations. Recruiting these groups is notoriously complex, and, unfortunately, many investigators, contract research organizations, and drug and device makers still fail to do so effectively.
As a multicultural health care communications expert, Sensis set out to answer two questions:
- Why don’t African, Asian, and Hispanic American audiences participate in medical research?
- What would encourage these audiences to participate?
Read the REPORT
Sign-up to receive access to all reports.
In April 2022, Sensis conducted an online survey of adults ages 18 and older from a nationally representative sample based on U.S. Census regions. 1,727 adults completed the survey with a median response time of 14 minutes.
Our survey asked respondents about their:
- demographics (which we also used for screening)
- general health
- thoughts on medical research / clinical trials
- trust in institutions
- participation in medical research / clinical trials
Sensis oversampled for African, Asian, and Hispanic Americans to ensure that our findings would have statistical significance. We also oversampled for older Americans, as older adults are typically poorly represented in clinical trials, even though they are the target audience for most medical research.
|WHITE, CAUCASIAN AMERICANS||511|
|BLACK, AFRICAN AMERICANS||414|
|HISPANIC, LATINO/LATINA AMERICANS||512|